|
|
| MRD / Regn No. |
: 4233 |
Date |
: 03/07/2026 |
| Patient Name |
: Naina Baid |
Age & Gender |
: 50 Yrs. / Female |
| Contact No. |
: 9007054935 |
UHID |
: |
| Ht / Wt / BMI |
: 162 / 97 / 36.96 |
BP S / BP D |
: 116 / 82 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (13/Sep/2000) | DYSLIPIDEMIA (13/Sep/2022) | METFORMIN INTOLERANCE (24/Aug/2023) | |
| Salient Investigations |
: |
CREATININE: 0.55 | EGFR EGLOMERULAR FILTRATION RATE: 125.26 mL/min/1.73m2 | HB HEMOGLOBIN: 13.4 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8 % | LDL LOW DENSITY LIPOPROTEIN: 99 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ATORVASTATIN 20 MG
X-TOR |
PO |
0-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
2 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
40-0-35 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
TABLET DAPAGLIFLOZIN 10 MG
FORXIGA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
4 |
ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 03/Jan/2027 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR: SPOT SAMPLE |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |